The dermatologic clinical and research interests of David A. Wetter, M.D., include autoimmune connective tissue diseases and rheumatologic skin diseases (lupus erythematosus, dermatomyositis, vasculitis, morphea and other sclerosing skin conditions); medical dermatology; hospital dermatology; cutaneous manifestations of systemic disease; and use of systemic medications to treat dermatologic disease.
- Cutaneous vasculitis
- Pyoderma gangrenosum
- Erythema multiforme
- Treatment-refractory cutaneous lupus
- Life-threatening drug eruptions, including Stevens-Johnson syndrome and acute generalized exanthematous pustulosis
- Paradoxical autoimmune side effects of tumor necrosis factor-alpha inhibitors, including psoriasis, lupus and vasculitis
Significance to patient care
Dr. Wetter's clinical research strives to provide information to patients about rare and severe dermatologic conditions; describe effective therapies for patients with difficult to treat dermatologic conditions; and create new knowledge and understanding that will help health care providers across the world improve treatment of patients with medical dermatologic skin diseases.
- Poster winner, Research Category, National Medical Student Abstract Competition, American College of Physicians, 2004